- Home
- JHX vs RVTY Comparison
JHX vs RVTY Comparison
Compare JHX & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHX
- RVTY
- Stock Information
- Founded
- JHX 1888
- RVTY 1937
- Country
- JHX Ireland
- RVTY United States
- Employees
- JHX N/A
- RVTY N/A
- Industry
- JHX Building Materials
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- JHX Industrials
- RVTY Industrials
- Exchange
- JHX Nasdaq
- RVTY Nasdaq
- Market Cap
- JHX 13.4B
- RVTY 15.1B
- IPO Year
- JHX N/A
- RVTY N/A
- Fundamental
- Price
- JHX $36.13
- RVTY $109.52
- Analyst Decision
- JHX Hold
- RVTY Buy
- Analyst Count
- JHX 3
- RVTY 16
- Target Price
- JHX N/A
- RVTY $129.40
- AVG Volume (30 Days)
- JHX 67.3K
- RVTY 1.0M
- Earning Date
- JHX 11-12-2024
- RVTY 11-04-2024
- Dividend Yield
- JHX N/A
- RVTY 0.26%
- EPS Growth
- JHX N/A
- RVTY N/A
- EPS
- JHX 1.01
- RVTY 2.06
- Revenue
- JHX $3,935,900,000.00
- RVTY $2,721,555,000.00
- Revenue This Year
- JHX $1.87
- RVTY $2.34
- Revenue Next Year
- JHX $10.17
- RVTY $5.58
- P/E Ratio
- JHX $35.69
- RVTY $52.34
- Revenue Growth
- JHX 5.47
- RVTY N/A
- 52 Week Low
- JHX $29.88
- RVTY $86.30
- 52 Week High
- JHX $43.57
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- JHX 60.35
- RVTY 28.31
- Support Level
- JHX $31.79
- RVTY $118.98
- Resistance Level
- JHX $33.60
- RVTY $120.85
- Average True Range (ATR)
- JHX 0.95
- RVTY 4.43
- MACD
- JHX 0.51
- RVTY -0.95
- Stochastic Oscillator
- JHX 92.97
- RVTY 1.48
About JHX James Hardie Industries plc (Ireland)
James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.